AGI.do

Products

What will AGI do for Aconiazide?

This classification denotes an antitubercular agent with the molecular formula C15H13N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8OKQ9NS8MO, chemically known as 4-pyridinecarboxylic acid, ((2-(carboxymethoxy)phenyl)methylene)hydrazide but more generally known as aconiazide, which bears US NIH Compound Identifier 5391612. European Medicines Agency schedules Aconiazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05246MIG. The term ACONIAZIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). ACONIAZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C1C(CCCC1)/C=N\NC(=O)C1CCNCC1)CC(=O)O.

How AGI delivers it

Four ways AGI delivers for Aconiazide

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aconiazide, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aconiazide, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aconiazide connects

measured by

  • Assay Puritymodel
  • Particle Size Distributionmodel
  • Related Substances Contentmodel
  • Residual Solvent Contentmodel

Go deeper

Explore Aconiazide

Read the deeper take on agi.asView as markdown